• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Going Global to Ease Drug Trial Process

    Contract research organization Parexel is exploiting its global footprint to rapidly enroll patients in drug studies.

  2. Generic Biologics Face Uphill Battle

    Morningstar generic-pharmaceuticals analyst Brian Laegeler discusses the outlook for generic biologics in the U.S. given a strong branded-drug lobby and complex manufacturing processes.

  3. After Reform, Opportunity

    Associate director for health-care analysis Alex Morozov on the uncertainty-overhang relief, biggest winners, and best values in post-reform health care.

  4. The Friday Five

    Five stats from the market and the stories behind them. This week: a steep 41% dividend cut, a surprising 12% sales gain, and more.

  1. Onyx Pharmaceuticals ONXX Q4 2012 Earnings Call Transcript

    Welcome to the Onyx Pharmaceuticals Conference Call. My name is Ellen, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.

  2. Alexion Pharmaceuticals ALXN Q4 2012 Earnings Call Transcript

    Good morning and welcome to the Alexion Pharmaceuticals Incorporated Fourth Quarter and Full Year 2012 Results Conference Call. Today's call is being recorded.

  3. Amgen AMGN Q4 2012 Earnings Call Transcript

    My name is Marvin, and I will be your conference facilitator today for Amgen's Fourth Quarter and Full Year 2012 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the last speaker's ...

  4. Schwab Sector Views: Consumer Concerns

     

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.